SOAT1 and metabolic disease: JAK-STAT pathway is dysregulated in the context of obesity and metabolic disease, moreover, JAK-STAT related proteins was involved in the insulin cascade response and considered as the treatment of obesity and diabetes (Collotta et al. 2023; Dodington et al. 2018).